Journal
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
Volume 5, Issue 1, Pages 9-19Publisher
W F S B P-WORLD FEDERATION SOCBIOLOGICAL PSYCHIATRY
DOI: 10.1080/15622970410029902
Keywords
schizophrenia; long-term treatment of schizophrenia; oral long-term treatment; depot neuroleptics
Categories
Ask authors/readers for more resources
Schizophrenia still has a poorer outcome than other affective disorders. One possible way to improve the long-term outcome of schizophrenic patients is to optimise long-term treatment with the aim to minimise the number of relapses and to reduce residual symptoms. Atypical antipsychotics have various advantages over atypical neuroleptics. The first depot formulation of an atypical neuroleptic appears to be a further positive step to improve the possibilities of an optimal long-term treatment for schizophrenia.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available